LaBarre Michael J. — SEC Form 4 filings
SEC reporting owner CIK 1507174. 21 Form 4 filings on record with FilingPulse; latest filed 2025-02-27.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2024-01-18 to 2025-02-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 30 legs across 11 filings — 211,697 shares, $10,430,031 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 87.
- Largest priced transaction: sale of 10,000 shares @ $62.88 ($628,780) in HALOZYME THERAPEUTICS, INC., filed 2024-09-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. (HALO) | SVP, CHIEF TECHNICAL OFFICER | 21 | — | 30 legs · 211,697 sh · $10,430,031 | 87 |
Form 4 filings — LaBarre Michael J.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-02-27 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale (S): 9,300 @ $58.01 · Sale (S): 700 @ $58.67 · Sale (S): 9,400 @ $58.09 · Sale (S): 600 @ $58.65 · Sale (S): 1,597 @ $58.25 · Sale (S): 100 @ $58.74 | EDGAR |
| 2025-02-24 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 4,747 @ $0 · Tax withholding (F): 2,410 @ $57.75 · Option exercise (M): 4,747 (derivative) @ $0 | EDGAR |
| 2025-02-21 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/award (A): 11,902 (derivative) @ $0 · Grant/award (A): 11,230 (derivative) @ $0 | EDGAR |
| 2025-02-18 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 3,386 @ $0 · Tax withholding (F): 1,304 @ $58.29 · Option exercise (M): 20,891 @ $0 · Tax withholding (F): 8,721 @ $58.29 · Option exercise (M): 6,112 @ $0 · Tax withholding (F): 3,103 @ $58.29 · +6 more | EDGAR |
| 2025-02-14 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/award (A): 7,262 (derivative) @ $0 · Grant/award (A): 4,177 (derivative) @ $0 · Grant/award (A): 4,921 (derivative) @ $0 · Grant/award (A): 20,342 (derivative) @ $0 | EDGAR |
| 2024-10-16 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 5,509 @ $16.65 · Option exercise (M): 4,491 @ $19.98 · Sale (S): 9,923 @ $53.74 · Sale (S): 77 @ $54.24 · Option exercise (M): 10,000 @ $19.98 · Sale (S): 10,000 @ $53.26 · +3 more | EDGAR |
| 2024-09-18 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 10,000 @ $16.65 · Sale (S): 10,000 @ $62.88 · Option exercise (M): 10,000 @ $16.65 · Sale (S): 7,963 @ $61.89 · Sale (S): 2,037 @ $62.58 · Option exercise (M): 10,000 (derivative) @ $0 · +1 more | EDGAR |
| 2024-08-27 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 5,580 @ $18.41 · Option exercise (M): 5,580 (derivative) @ $0 | EDGAR |
| 2024-08-21 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 10,000 @ $16.65 · Sale (S): 10,000 @ $61.05 · Option exercise (M): 10,000 @ $16.65 · Sale (S): 9,900 @ $61.74 · Sale (S): 100 @ $62.34 · Option exercise (M): 10,000 (derivative) @ $0 · +1 more | EDGAR |
| 2024-07-24 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 10,000 @ $8.11 · Sale (S): 4,709 @ $54.46 · Sale (S): 5,291 @ $55.27 · Option exercise (M): 1,715 @ $8.11 · Option exercise (M): 8,285 @ $16.65 · Sale (S): 10,000 @ $55.12 · +3 more | EDGAR |
| 2024-06-20 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 10,000 @ $8.11 · Sale (S): 10,000 @ $49.43 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-05-22 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 10,000 @ $8.11 · Sale (S): 10,000 @ $45.16 · Option exercise (M): 10,000 @ $8.11 · Sale (S): 10,000 @ $45.38 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-04-17 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 10,000 @ $8.11 · Sale (S): 10,000 @ $38.35 · Option exercise (M): 10,000 @ $8.11 · Sale (S): 10,000 @ $38.49 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-03-26 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 8,436 @ $12.07 · Option exercise (M): 292 @ $16.78 · Option exercise (M): 2,890 @ $8.11 · Option exercise (M): 8,436 (derivative) @ $0 · Option exercise (M): 292 (derivative) @ $0 · Option exercise (M): 2,890 (derivative) @ $0 | EDGAR |
| 2024-03-13 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 10,000 @ $12.07 · Sale (S): 10,000 @ $41.64 · Option exercise (M): 6,449 @ $12.07 · Option exercise (M): 3,551 @ $8.11 · Sale (S): 10,000 @ $42.27 · Option exercise (M): 10,000 (derivative) @ $0 · +2 more | EDGAR |
| 2024-02-28 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale (S): 10,000 @ $39.95 · Sale (S): 2,529 @ $39.56 · Option exercise (M): 7,471 @ $8.11 · Sale (S): 7,471 @ $39.54 · Option exercise (M): 7,471 (derivative) @ $0 | EDGAR |
| 2024-02-27 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/award (A): 19,674 (derivative) @ $0 · Grant/award (A): 18,985 (derivative) @ $0 | EDGAR |
| 2024-02-20 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 6,112 @ $0 · Tax withholding (F): 3,097 @ $36.10 · Option exercise (M): 4,264 @ $0 · Tax withholding (F): 2,160 @ $36.10 · Option exercise (M): 6,112 (derivative) @ $0 · Option exercise (M): 4,264 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 3,386 @ $0 · Tax withholding (F): 1,208 @ $35.91 · Grant/award (A): 8,479 @ $0 · Tax withholding (F): 3,832 @ $35.91 · Option exercise (M): 3,386 (derivative) @ $0 | EDGAR |
| 2024-02-13 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 8,133 @ $0 · Tax withholding (F): 2,901 @ $35.49 · Option exercise (M): 8,133 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Option exercise (M): 10,000 @ $12.07 · Sale (S): 10,000 @ $36 · Option exercise (M): 10,000 @ $12.07 · Sale (S): 10,000 @ $36 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1507174 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →